In 100 adults with alcohol use disorder, intranasal oxytocin (up to 70 IU/day) for 12 weeks did not significantly reduce the weekly percentage of heavy drinking days versus placebo over 10 weeks of maintenance; it was well tolerated, with mild adverse events.
RCTn = 100
Tiouririne et al. Intranasal Oxytocin for Alcohol Use Disorder: A Randomized, Double-Blind, Placebo-Controlled Multisite Trial Assessing Efficacy and Safety